Dietary lipid lowering modifies plaque phenotype in rabbit atheroma after angioplasty: A potential role of tissue factor

Circulation

Volumn 108, Issue 14, 2003, Pages 1740-1745

  Jeanpierre, Emmanuelle ^c   Le Tourneau, Thierry ^c   Six, Isabelle ^c   Zawadzki, Christophe ^c   Van Belle, Eric ^c   Ezekowitz, Michael D ^a   Bordet, Régis ^c   Susen, Sophie ^c   Jude, Brigitte ^b   Corseaux, Delphine ^c  

^a YALE UNIVERSITY   (United States)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c NONE

Author keywords

Angioplasty; Atherosclerosis; Lipids; Tissue factor

Indexed keywords

THROMBOPLASTIN;

ANGIOGENESIS; ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; BLOOD VESSEL WALL; CELL MIGRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; THROMBOGENESIS; THROMBOSIS;

EID: 0141919731     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000089370.84709.51     Document Type: Article

References (29)

1. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J. 1994;8:385-390.
2. Chen J, Bierhaus A, Schiekofer S, et al. Tissue factor: a receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost. 2001;86:334-345.
3. Mackman N. Regulation of the tissue factor gene. FASEB J. 1995;9:883-889.
4. Wilcox JN, Smith KM, Schwartz SM, et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 1989;86:2839-2843.
5. Annex BH, Denning SM, Channon KM, et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 1995;91:619-622.
6. Marmur JD, Thiruvikraman SV, Fyfe BS, et al. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226-1232.
7. Ardissino D, Merlini PA, Ariëns R, et al. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet. 1997;349: 769-771.
8. Ardissino D, Merlini PA, Bramucci E, et al. Thrombogenic potential of human coronary atherosclerotic plaques. Blood. 2001;98:2726-2729.
9. Kato K, Elsayed YA, Namoto M, et al. Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits. Thromb Res. 1996;82:335-347.
10. Camera M, Toschi V, Comparato C, et al. Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin. Thromb Haemost. 2002;87:748-755.
11. Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 1998;97:2433-2444.
12. Gertz SD, Fallon JT, Gallo R, et al. Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries. Circulation. 1998;98:580-587.
13. Speidel CM, Eisenberg PR, Ruf W, et al. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation. 1995;92:3323-3330.
14. Corseaux D, Le Tourneau T, Six I, et al. Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginine. Circulation. 1998;98:1776-1782.
15. Aikawa M, Voglic SJ, Sugiyama S, et al. Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation. 1999;100:1215-1222.
16. Van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
17. Schuff-Werner P, Claus G, Armstrong VW, et al. Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis. 1989;78:109-112.
18. Lesnik P, Rouis M, Skarlatos S, et al. Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. Proc Natl Acad Sci USA. 1992;89:10370-10374.
19. Aikawa M, Rabkin E, Voglic SJ, et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res. 1998;83:1015-1026.
20. Aikawa M, Rabkin E, Sugiyama S, et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001;103:276-283.
21. McCarthy MJ, Loftus IM, Thompson MM, et al. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg. 1999;30:261-268.
22. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
23. Versteeg HH, Peppelenbosch MP, Spek CA. The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling? Thromb Haemost. 2001;86:1353:1359.
24. Ollivier V, Bentolila S, Chabbat J, et al. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood. 1998;91:2698-2703.
25. Makin AJ, Chung NA, Silverman SH, et al. Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis? Clin Sci. 2003;104:397-404.
26. Blann AD, Belgore FM, Constans J, et al. Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. Am J Cardiol. 2001;87:1160-1163.
27. Rugeri L, Susen S, Bard JM, et al. Tissue factor response of circulating monocytes is decreased in patients with hyperlipidemia. Thromb Res. 1999;96:283-292.
28. Kakuta T, Currier JW, Haudenschild CC, et al. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 1994;89:2809-2815.
29. Gimple LW, Gertz SD, Haber HL, et al. Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits: a quantitative angiographic and histopathological study. Circulation. 1992;86:1536-1546.